Gene study for lupus
Part of Immune system & allergy clinical trials.
This study looks at a specific gene (ICOS) in people with lupus to better understand the condition. It involves a blood test to check for genetic markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lupus (SLE).
- You are willing to give a blood sample for genetic testing.
- You are not pregnant or breastfeeding.
- You do not have another autoimmune disease or cancer.
- You can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special type of stem cell treatment (called UC-MSC) can help calm lupus when standard medicines aren't enough. It's for people with active lupus who have tried other non-steroid medications.
This study looks at a protein called CXCL5 in the blood of people with lupus (SLE) to see if it relates to how active their disease is. It will help researchers understand more about lupus and possibly find new ways to track or treat it.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study creates a registry for people with systemic lupus erythematosus (SLE) to track the disease over time. Joining helps researchers learn more about lupus and may improve care for future patients.
This study follows people newly diagnosed with lupus (SLE) to understand how the disease develops over time. It looks at what happens before treatment starts or soon after diagnosis, and aims to improve care for lupus patients across Europe.
This study looks at blood and immune cell markers (autoantibodies and immune cell “signatures”) to better understand autoimmune conditions, including lupus. It may help researchers identify which markers are linked to disease and how immune cells respond after vaccination.
Hear when a new Systemic Lupus Erthematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.